HOXD4
Basic information
Region (hg38): 2:176151549-176153226
Previous symbols: [ "HOX4B", "HOX4" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (12 variants)
- not provided (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HOXD4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 12 | 13 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region ? | 1 | 1 | ||||
non coding ? | 0 | |||||
Total | 0 | 0 | 12 | 1 | 1 |
Variants in HOXD4
This is a list of pathogenic ClinVar variants found in the HOXD4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-176151697-G-A | Likely benign (Aug 16, 2018) | |||
2-176151724-G-C | not specified | Uncertain significance (Dec 15, 2023) | ||
2-176151731-G-A | not specified | Uncertain significance (Jul 08, 2022) | ||
2-176151746-G-A | not specified | Uncertain significance (Jun 10, 2022) | ||
2-176151768-C-T | Benign (Feb 16, 2018) | |||
2-176151776-C-A | not specified | Uncertain significance (Feb 10, 2022) | ||
2-176151793-C-T | not specified | Uncertain significance (Aug 17, 2021) | ||
2-176151808-G-A | not specified | Uncertain significance (May 30, 2022) | ||
2-176151875-A-T | Leukemia, acute lymphoblastic, susceptibility to | Uncertain significance (Apr 01, 2005) | ||
2-176151907-C-A | not specified | Uncertain significance (Sep 01, 2021) | ||
2-176151944-C-A | not specified | Uncertain significance (Jul 12, 2023) | ||
2-176151982-G-C | not specified | Uncertain significance (Sep 22, 2023) | ||
2-176152033-T-C | not specified | Uncertain significance (Feb 28, 2024) | ||
2-176152072-G-T | Benign (Jun 29, 2018) | |||
2-176152722-G-A | not specified | Uncertain significance (Jul 19, 2023) | ||
2-176152725-G-A | not specified | Uncertain significance (May 31, 2023) | ||
2-176152761-G-T | not specified | Uncertain significance (Nov 21, 2022) | ||
2-176152867-C-G | not specified | Uncertain significance (Dec 06, 2022) | ||
2-176152883-C-A | not specified | Uncertain significance (Aug 10, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HOXD4 | protein_coding | protein_coding | ENST00000306324 | 2 | 2005 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00545 | 0.904 | 125729 | 0 | 19 | 125748 | 0.0000756 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.423 | 169 | 154 | 1.10 | 0.00000769 | 1610 |
Missense in Polyphen | 66 | 58.251 | 1.133 | 631 | ||
Synonymous | -1.18 | 86 | 73.2 | 1.18 | 0.00000391 | 539 |
Loss of Function | 1.45 | 5 | 9.93 | 0.504 | 4.30e-7 | 109 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000290 | 0.0000290 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000708 | 0.0000703 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000327 | 0.000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis.;
- Pathway
- Activation of anterior HOX genes in hindbrain development during early embryogenesis
(Consensus)
Recessive Scores
- pRec
- 0.127
Intolerance Scores
- loftool
- 0.266
- rvis_EVS
- -0.21
- rvis_percentile_EVS
- 38.58
Haploinsufficiency Scores
- pHI
- 0.569
- hipred
- N
- hipred_score
- 0.361
- ghis
- 0.423
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.841
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hoxd4
- Phenotype
- growth/size/body region phenotype; craniofacial phenotype; skeleton phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Zebrafish Information Network
- Gene name
- hoxd4a
- Affected structure
- vasculature
- Phenotype tag
- abnormal
- Phenotype quality
- lacks parts or has fewer parts of type
Gene ontology
- Biological process
- skeletal system development;multicellular organism development;anterior/posterior pattern specification;positive regulation of transcription by RNA polymerase II;embryonic skeletal system morphogenesis
- Cellular component
- nucleus;nucleoplasm;cell junction
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;activating transcription factor binding